Loading...
 
Back to the list
Mediterr J Rheumatol 2018;29(2):86-8
Article Links
Patient with ankylosing spondylitis and scleroderma renal crisis
Aliki I. Venetsanopoulou, Ourania Argyropoulou, Athanasios G. Tzioufas
Authors Information

Department of Pathophysiology, Medical School, University of Athens, Athens, Greece

Keywords: Ankylosing spondylitis, Systemic Scleroderma
References
  1. Distler J H, Schett G, Gay S, Distler O. The controversial role of tumor necrosis factor alpha in fibrotic diseases. Arthritis Rheum 2008;58:2228-35. https://doi.org/10.1002/art.23645.
  2. Chua C C, Chua B H: Tumor necrosis factor-alpha induces MRNA for collagenase and TIMP in human skin fibroblasts. Connect Tissue Res 1990;25:161-70.
  3. Mauviel A, Daireaux M, Redini F, Galera P, Loyau G, Pujol J P: Tumor necrosis factor inhibits collagen and fibronectin synthesis in human dermal fibroblasts. FEBS Lett 1988;236:47-52.
  4. Liu J Y, Brass D M, Hoyle G W, Brody A R.TNF-alpha receptor knockout mice are protected from the fibroproliferative effects of inhaled asbestos fibers. Am J Pathol 1998;153:1839-47.
  5. Phumethum V, Jamal S, Johnson S R. Biologic therapy for systemic sclerosis: a systematic review. J Rheumatol 2011;38:289-96.
  6. Stewart F A, Gavino A C, Elewski B E. New side effect of TNF-alpha inhibitors: morphea. Skinmed 2013;11:59-60. PubMed PMID: 23540081.
  7. Ramírez J, Hernández M V, Galve J, Cañete J D, Sanmartí R. Morphea associated with the use of adalimumab: a case report and review of the literature. Mod Rheumatol 2012;22:602-4. https://doi.org/10.1007/s10165-011-0550-4. Epub 2011 Nov18. Review. PubMed PMID: 22095405.
  8. Mattozzi C, Richetta A G, Cantisani C, Giancristoforo S, D'Epiro S, Gonzalez Serva A, et al. Morphea, an unusual side effect of anti-TNF-alpha treatment. Eur J Dermatol 2010;20:400-1. https://doi.org/10.1684/ejd.2010.0946. Epub 2010 Mar 19. PubMed PMID: 20299314.
  9. Bosello S, De Santis M, Tolusso B, Zoli A, Ferraccioli G. Tumor necrosis factor-alpha inhibitor therapy in erosive polyarthritis secondary to systemic sclerosis. Ann Intern Med 2005;143:918-20.
  10. Olivieri I, Gemignani G, Balagi M, et al. Concomitant systemic lupus erythematosus and ankylosing spondylitis. Ann Rheum Dis 1990;49:323e4.
  11. Lee J K, Jung S S, Kim T H, Jun J B, Yoo D H, Kim S Y. Coexistence of ankylosing spondylitis and mixed connective tissue disease in a single patient. Clin Exp Rheumatol 1999;17:263.
  12. Kotevoglu N. Coexistence of ankylosing spondylitis and Behcet’s disease. Two cases with atypical presentation and course. Scand J Rheumatol 2003;32:184e5.
  13. Ouédraogo D D, Palazzo E, Nlomé-Nzé M, Somogyi-Demerjian N, Meyer O. Ankylosing spondylitis and systemic sclerosis: a rare combination. Joint Bone Spine 2009;76:290-2.
  14. Soledade C S, Sampaio-Barros P D, Samara A M, Marques-Neto J F. Unusual association of systemic sclerosis and ankylosing spondylitis. Clin Rheumatol 2005;24:652-4.
  15. Kayser C, Alvarenga M C, Neves A S, Gerbase-De Lima M, Andrade L E. Severe ankylosing spondylitis and diffuse systemic sclerosis: case report of a genetic trap. Scand J Rheumatol 2005;34:145-7.